131 related articles for article (PubMed ID: 32016460)
1. MicroRNA‑27a‑3p promotes epithelial‑mesenchymal transition by targeting NOVA alternative splicing regulator 1 in gastric cancer.
Li K; Zhu X; Chen X; Wang X
Mol Med Rep; 2020 Mar; 21(3):1615-1622. PubMed ID: 32016460
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
3. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
[TBL] [Abstract][Full Text] [Related]
4. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1.
Luo Y; Hao T; Zhang J; Zhang M; Sun P; Wu L
Int J Mol Med; 2019 Sep; 44(3):1172-1182. PubMed ID: 31524231
[TBL] [Abstract][Full Text] [Related]
7. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
9. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.
Shen B; Zhang Y; Yu S; Yuan Y; Zhong Y; Lu J; Feng J
FEBS Lett; 2015 Oct; 589(20 Pt B):3205-11. PubMed ID: 26391641
[TBL] [Abstract][Full Text] [Related]
12. The expression level changes of microRNAs 200a/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition.
Mirzaei S; Baghaei K; Parivar K; Hashemi M; Asadzadeh Aghdaei H
Eur J Pharmacol; 2019 Aug; 857():172426. PubMed ID: 31150646
[TBL] [Abstract][Full Text] [Related]
13. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.
Wu ZH; Lin C; Liu CC; Jiang WW; Huang MZ; Liu X; Guo WJ
Biochem Biophys Res Commun; 2018 Jul; 501(4):1068-1073. PubMed ID: 29777710
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer.
Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T
Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809
[TBL] [Abstract][Full Text] [Related]
15. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
18. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
[TBL] [Abstract][Full Text] [Related]
19. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
Wang S; Chen Y; Yu X; Lu Y; Wang H; Wu F; Teng L
Pathol Res Pract; 2019 Apr; 215(4):676-682. PubMed ID: 30635217
[TBL] [Abstract][Full Text] [Related]
20. LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer.
Liu YW; Sun M; Xia R; Zhang EB; Liu XH; Zhang ZH; Xu TP; De W; Liu BR; Wang ZX
Cell Death Dis; 2015 Jul; 6(7):e1802. PubMed ID: 26136075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
